Fastbase, Lambert to Implement Cancer Diagnostic Platform

Proteomic technology developer Fastbase Solutions and imaging solutions developer Lambert Instruments BV have announced a strategic partnership to implement a new cancer diagnostics platform.

The system will be delivered using Lambert Instruments’ FLIM [fluorescence lifetime imaging microscopy] Attachment technology. Fastbase Solutions’ image acquisition and analysis platform is based on fluorescence lifetime imaging technology developed by Lambert Instruments.

”The Lambert Instruments FLIM technology provides us with the tools we need to build our quantitative biomarker platform and accelerate our growth as a young company,” said Banafshé Larijani, chief sales officer of Fastbase.

Lambert Instruments develops advanced imaging solutions for low-light applications. Fastbase Solutions implements new technology for functional proteomic insight.